The court has also declined an application by SFO for permission to appeal to the English Court of Appeal, even SFO has the right to appeal to the court directly, Ranbaxy informed the BSE today.
Ranbaxy is a responsible company committed to providing high quality generic medicines at affordable prices to patients around the world, it said.
Ranbaxy UK and five other companies were accused of an alleged price fixing to defraud the UK health service.